Bright minds biosciences closes us$35 million non-brokered private placement

Vancouver, british columbia, nov. 04, 2024 (globe newswire) -- bright minds biosciences inc. (cse: drug) (nasdaq: drug) (“bright minds” or the “company”) announces that further to its news release of october 18, 2024, the company has closed a non-brokered private placement of 1,612,902 common shares in the capital of the company (“shares”) at a price of usd$21.70 per share for aggregate gross proceeds of usd$35,000,000 (the “offering”).
DRUG Ratings Summary
DRUG Quant Ranking